← Live Studies
Oral semaglutide dose study for weight management
Compares investigational lower once-daily doses of oral semaglutide with placebo tablets, to help choose a lower dose for weight management.
Who it's for
- Age 18+
- BMI ≥30, or ≥27 with a weight-related condition
- Additional lab and medication restrictions
Full eligibility rules apply. The study team decides who can take part.
Where it runs
4 research locations in California and Hawaii.
California
- Headlands Research California, LLCEscondido, CA
- National Research Institute - Huntington ParkHuntington Park, CA
- Los Angeles Institute for Metabolic ResearchLos Angeles, CA
Hawaii
- East West Med Res InstHonolulu, HI
Site recruitment may change. The official record lists every location, including outside these states.
Interested in this study?
Ask us about it, or refer a patient. Taking part is voluntary, and the study team decides who can join.

